Long-Term Follow-up Study of FURESTEM-AD in Patients With Atopic Dermatitis(K0106)

NCT07582237 | Active Not Recruiting

• 1 other identifier: K0106-E
• Study Type: observational
• Target: 262
• Locations: 1 country
• Sites: 1

Brief Summary

Long-Term Follow-up Study of Subjects With Moderate to Severe Chronic Atopic Dermatitis Who Had Administered FURESTEM-AD Inj. in K0106 Study

Conditions

Dermatitis, Atopic

Keywords

Atopic Dermatitis; AD; Stem Cell; Furestem

Outcome Measures

Primary Outcomes (1)

• Safety Assessment

  Rate and Number of AESI(Adverse Event of Special Interest) and SS(Special Situation)

  5 years follow-up after treatment

Secondary Outcomes (3)

• EASI(Eczema Area and Severity Index) Score

  1 year, 2 years, 3 years after treatment

• IGA(Investigator's Global Assessment) Score

  1 year, 2 years, 3 years after treatment

• Pruritus NRS(Numerical Rating Scale) Score

  1 year, 2 years, 3 years after treatment

Eligibility Criteria

• Age: 19 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Those who participated in the K0106 clinical trial, received FURESTEM-AD Inj., and consented to participate in the long-term follow-up study

You may qualify if:

• Those who participated in the K0106 clinical trial and received FURESTEM-AD Inj
• Those who understand and voluntarily sign an informed consent form

You may not qualify if:

• None

Sponsors & Collaborators

• Kang Stem Biotech Co., Ltd.: lead

Study Sites (1)

Bucheon Hospital, Soonchunhyang University

Bucheon-si, South Korea

Location

MeSH Terms

Conditions

Dermatitis, Atopic

Condition Hierarchy (Ancestors)

Skin Diseases, Genetic; Genetic Diseases, Inborn; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Dermatitis; Skin Diseases; Skin and Connective Tissue Diseases; Skin Diseases, Eczematous; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Study Officials

• Yeonglib Park, professor (CI)

  Bucheon Hospital, Soonchunhyang University

  PRINCIPAL INVESTIGATOR

• Yangwon Lee, professor

  Konkuk University Hospital

  PRINCIPAL INVESTIGATOR

• Sanguk Son, professor

  Korea University Ansan Hospital

  PRINCIPAL INVESTIGATOR

• Bakrin Yoo, professor

  Gangdong Kyunghee University Hospital

  PRINCIPAL INVESTIGATOR

• Jihyun Lee, professor

  Seoul St. Mary's Hospital

  PRINCIPAL INVESTIGATOR

• Donghoon Lee, professor

  Seoul National University Hospital

  PRINCIPAL INVESTIGATOR

• Chanho Na, professor

  Chosun University Hospital

  PRINCIPAL INVESTIGATOR

• Yooin Bae, professor

  Hallym University Dongtan Seongsim Hospital

  PRINCIPAL INVESTIGATOR

• Hyunchang Ko, professor

  Yangsan Pusan National University Hospital

  PRINCIPAL INVESTIGATOR

• Younghyun Jang, professor

  Kyungpook National University Hospital

  PRINCIPAL INVESTIGATOR

• Hoon Kang, professor

  The Catholic University of Korea Eunpyeong St. Mary's Hospital

  PRINCIPAL INVESTIGATOR

• Minkyung Shin, professor

  Kyunghee University Hospital

  PRINCIPAL INVESTIGATOR

• Sanghyun Cho, professor

  Catholic University Incheon St. Mary's Hospital

  PRINCIPAL INVESTIGATOR

• Cheonuk Park, professor

  Hallym University Kangnam Sacred Heart Hospital

  PRINCIPAL INVESTIGATOR

• Jooyeon Ko, professor

  Hanyang University

  PRINCIPAL INVESTIGATOR

• Taeyoung Han, professor

  Nowon Eulji University Hospital

  PRINCIPAL INVESTIGATOR

• Jiyoung Ahn, professor

  National medical center

  PRINCIPAL INVESTIGATOR

• Yuchan Kim, professor

  Ajou University School of Medicine

  PRINCIPAL INVESTIGATOR

• Sungyeol Lee, professor

  Soon Chun Hyang University

  PRINCIPAL INVESTIGATOR

• Junhong Min, professor

  KangWon National University Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 6, 2026
• First Posted: May 12, 2026
• Study Start: October 5, 2021
• Primary Completion (Estimated): August 21, 2028
• Study Completion (Estimated): February 21, 2029
• Last Updated: May 12, 2026

Record last verified: 2026-05

Locations

KR (1)